AB084. Docetaxel therapy for hormone-sensitive prostate cancer—single center result

BACKGROUND: Androgen-deprivation therapy (ADT) has been the treatment for metastatic prostate cancer for more 75 years. We assessed whether concomitant treatment with ADT added to docetaxel would result in patients newly-diagnosed metastatic hormone-sensitive prostate cancer for longer overall survi...

Full description

Saved in:
Bibliographic Details
Published in:Transl Androl Urol
Main Authors: Shao, Qiang, Du, Yuan, Zhang, Fengbo, Tian, Ye
Format: Artigo
Language:Inglês
Published: AME Publishing Company 2015
Subjects:
Podium Lecture
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4708668/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2223-4683.2015.s084
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items